MUMBAI, India, Sept. 14 -- Intellectual Property India has published a patent application (202611088111 A) filed by Chitkara University on July 19, 2026, for Gemcitabine–quercetin Co-Loaded Self-Nanoemulsifying Drug Delivery System For Management Of Pancreatic Cancer.
Inventors include Rohit Sharma; Dr. Manish Kumar; Dr. Poonam Negi; Dr. Thakur Gurjeet Singh; and Dr. Sonia Dhiman.
The application for the patent was published on September 11, 2026, under issue no. 37/2026.
Abstract: The present invention relates to a self-nanoemulsifying drug delivery system (SNEDDS) comprising Gemcitabine and Quercetin for management of pancreatic cancer. The SNEDDS comprises Gemcitabine, Quercetin, Labrasol as an oil phase, Tween-80 as a surfactant, and...